The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Type 2 diabetes as a protein misfolding disease
Open accessAbstract
Type 2 diabetes is a highly prevalent and chronic metabolic disorder. Recent evidence suggests that formation of toxic aggregates of the islet amyloid polypeptide (IAPP) might contribute to β-cell dysfunction and disease. However, the mechanism of protein aggregation and associated toxicity is still unclear. Misfolding, aggregation and accumulation of diverse proteins in different organs is the hallmark in the group of protein misfolding disorders (PMDs), including highly prevalent illnesses affecting the central nervous system such as Alzheimer’s and Parkinson’s diseases. In this review we will discuss the current understanding of the mechanisms implicated in the formation of protein aggregates in pancreas and associated toxicity in the light of the longstanding knowledge from neurodegenerative disorders associated with protein misfolding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Self-citationType 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500
Bjørkøy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Øvervatn, A., Stenmark, H., & Johansen, T. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507002 · Cited by 3,276
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Autophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Aggresomes: A Cellular Response to Misfolded Proteins
Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Aggresomes, inclusion bodies and protein aggregation
Kopito, R. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01852-3 · Cited by 1,921
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
Ravikumar, B., Sarkar, S., Davies, J. E., Futter, M., Garcia-Arencibia, M., Green-Thompson, Z. W., Jimenez-Sanchez, M., Korolchuk, V. I., Lichtenberg, M., Luo, S., et al. (2010) · Physiological Reviews · doi:10.1152/physrev.00030.2009 · Cited by 1,727
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
Unfolding the role of protein misfolding in neurodegenerative diseases
Soto, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1007 · Cited by 1,506
Self-citationInflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330
A Role for Ubiquitin in Selective Autophagy
Kirkin, V., McEwan, D. G., Novak, I., & Dikic, I. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.026 · Cited by 1,239
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044
Demuro, A., Mina, E., Kayed, R., Milton, S. C., Parker, I., & Glabe, C. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500997200 · Cited by 1,041
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Ciechanover, A., & Brundin, P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00606-8 · Cited by 982
Amyloid ion channels: A common structural link for protein-misfolding disease
Quist, A., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., Kagan, B., Ghiso, J., & Lal, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502066102 · Cited by 982
Westermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D., & Johnson, K. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3881 · Cited by 976
Increased Risk of Type 2 Diabetes in Alzheimer Disease
Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950
Self-citationIslet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.
Westermark, P., Engström, U., Johnson, K. H., Westermark, G. T., & Betsholtz, C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5036 · Cited by 807
Pike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., Mathis, C. A., Klunk, W. E., Masters, C. L., & Rowe, C. C. (2007) · Brain · doi:10.1093/brain/awm238 · Cited by 789
Poitout, V., & Robertson, R. P. (2002) · Endocrinology · doi:10.1210/endo.143.2.8623 · Cited by 743
Leissring, M. A., Farris, W., Chang, A. Y., Walsh, D. M., Wu, X., Sun, X., Frosch, M. P., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00787-6 · Cited by 719
Functional Role of Caspase-1 and Caspase-3 in an ALS Transgenic Mouse Model
Li, M., Ona, V. O., Guégan, C., Chen, M., Jackson-Lewis, V., Andrews, L. J., Olszewski, A. J., Stieg, P. E., Lee, J.-P., Przedborski, S., et al. (2000) · Science · doi:10.1126/science.288.5464.335 · Cited by 716
Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases
Hetz, C., & Mollereau, B. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3689 · Cited by 684
Rapamycin alleviates toxicity of different aggregate-prone proteins
Berger, Z., Ravikumar, B., Menzies, F. M., Oroz, L. G., Underwood, B. R., Pangalos, M. N., Schmitt, I., Wullner, U., Evert, B. O., O'Kane, C. J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi458 · Cited by 657
Loss of Autophagy Diminishes Pancreatic β Cell Mass and Function with Resultant Hyperglycemia
Jung, H. S., Chung, K. W., Won Kim, J., Kim, J., Komatsu, M., Tanaka, K., Nguyen, Y. H., Kang, T. M., Yoon, K.-H., Kim, J.-W., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.013 · Cited by 647
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
Haataja, L., Gurlo, T., Huang, C. J., & Butler, P. C. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0037 · Cited by 612
Self-citationJanson, J., Ashley, R. H., Harrison, D., McIntyre, S., & Butler, P. C. (1999) · Diabetes · doi:10.2337/diabetes.48.3.491 · Cited by 612
Self-citationSaturated Fatty Acids Synergize with Elevated Glucose to Cause Pancreatic β-Cell Death
El-Assaad, W., Buteau, J., Peyot, M.-L., Nolan, C., Roduit, R., Hardy, S., Joly, E., Dbaibo, G., Rosenberg, L., & Prentki, M. (2003) · Endocrinology · doi:10.1210/en.2003-0410 · Cited by 587
Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes
Hull, R. L., Westermark, G. T., Westermark, P., & Kahn, S. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0405 · Cited by 583
Common mechanisms of amyloid oligomer pathogenesis in degenerative disease
Glabe, C. G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.017 · Cited by 569
Choi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., Chin, L.-S., & Li, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314124200 · Cited by 568
Atomic View of a Toxic Amyloid Small Oligomer
Laganowsky, A., Liu, C., Sawaya, M. R., Whitelegge, J. P., Park, J., Zhao, M., Pensalfini, A., Soriaga, A. B., Landau, M., Teng, P. K., et al. (2012) · Science · doi:10.1126/science.1213151 · Cited by 563
Evidence for Genetic Linkage of Alzheimer's Disease to Chromosome 10q
Bertram, L., Blacker, D., Mullin, K., Keeney, D., Jones, J., Basu, S., Yhu, S., McInnis, M. G., Go, R. C. P., Vekrellis, K., et al. (2000) · Science · doi:10.1126/science.290.5500.2302 · Cited by 519
Clark, A., Wells, C. A., BULEY, I. D., Cruickshank, J. K., Vanhegan, R. I., Matthews, D. R., Cooper, G. J. S., Holman, R. R., & Turner, R. C. (1988) · PubMed · Cited by 518
Targeting Proteins for Destruction by the Ubiquitin System: Implications for Human Pathobiology
Schwartz, A. L., & Ciechanover, A. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.051208.165340 · Cited by 492
A Unifying Role for Prions in Neurodegenerative Diseases
Prusiner, S. B. (2012) · Science · doi:10.1126/science.1222951 · Cited by 491
Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane
Engel, M. F. M., Khemtémourian, L., Kleijer, C. C., Meeldijk, H. J. D., Jacobs, J., Verkleij, A. J., de Kruijff, B., Killian, J. A., & Höppener, J. W. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708354105 · Cited by 466
Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin
Mirzabekov, T. A., Lin, M.-C., & Kagan, B. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1988 · Cited by 442
Snyder, H., Mensah, K., Theisler, C., Lee, J., Matouschek, A., & Wolozin, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208641200 · Cited by 420
Gong, B., Cao, Z., Zheng, P., Vitolo, O. V., Liu, S., Staniszewski, A., Moolman, D., Zhang, H., Shelanski, M., & Arancio, O. (2006) · Cell · doi:10.1016/j.cell.2006.06.046 · Cited by 420
Huang, C.-J., Lin, C.-Y., Haataja, L., Gurlo, T., Butler, A. E., Rizza, R. A., & Butler, P. C. (2007) · Diabetes · doi:10.2337/db07-0197 · Cited by 416
Self-citationThe endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients
Marchetti, P., Bugliani, M., Lupi, R., Marselli, L., Masini, M., Boggi, U., Filipponi, F., Weir, G. C., Eizirik, D. L., & Cnop, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0816-8 · Cited by 413
Proteasomal Inhibition by α-Synuclein Filaments and Oligomers
Lindersson, E., Beedholm, R., Højrup, P., Moos, T., Gai, W., Hendil, K. B., & Jensen, P. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306390200 · Cited by 397
The 3D profile method for identifying fibril-forming segments of proteins
Thompson, M. J., Sievers, S. A., Karanicolas, J., Ivanova, M. I., Baker, D., & Eisenberg, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511295103 · Cited by 395
Autophagy in human type 2 diabetes pancreatic beta cells
Masini, M., Bugliani, M., Lupi, R., del Guerra, S., Boggi, U., Filipponi, F., Marselli, L., Masiello, P., & Marchetti, P. (2009) · Diabetologia · doi:10.1007/s00125-009-1347-2 · Cited by 360
Cooper, G. J., Leighton, B., Dimitriadis, G. D., Parry-Billings, M., Kowalchuk, J. M., Howland, K., Rothbard, J. B., Willis, A. C., & Reid, K. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7763 · Cited by 355
Protein Misfolding and Neurodegeneration
Soto, C., & Estrada, L. D. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.56 · Cited by 352
Self-citationChételat, G., La Joie, R., Villain, N., Perrotin, A., de La Sayette, V., Eustache, F., & Vandenberghe, R. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.02.006 · Cited by 352
Genetic Classification of Primary Neurodegenerative Disease
Hardy, J., & Gwinn-Hardy, K. (1998) · Science · doi:10.1126/science.282.5391.1075 · Cited by 343
Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.
Janson, J., Soeller, W. C., Roche, P. C., Nelson, R. T., Torchia, A. J., Kreutter, D. K., & Butler, P. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7283 · Cited by 342
Self-citationAmylin deposition in the brain: A second amyloid in Alzheimer disease?
Jackson, K., Barisone, G. A., Diaz, E., Jin, L., DeCarli, C., & Despa, F. (2013) · Annals of Neurology · doi:10.1002/ana.23956 · Cited by 340
β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition
Jurgens, C. A., Toukatly, M. N., Fligner, C. L., Udayasankar, J., Subramanian, S. L., Zraika, S., Aston-Mourney, K., Carr, D. B., Westermark, P., Westermark, G. T., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.02.036 · Cited by 329
Role of IL-1β in type 2 diabetes
Dinarello, C. A., Donath, M. Y., & Mandrup-Poulsen, T. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32833bf6dc · Cited by 327
Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis
Meissner, F., Molawi, K., & Zychlinsky, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002396107 · Cited by 318
The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus
Westermark, P., & Wilander, E. (1978) · Diabetologia · doi:10.1007/bf01219652 · Cited by 290
Conversion of PrP to a Self-Perpetuating PrP Sc -like Conformation in the Cytosol
Ma, J., & Lindquist, S. (2002) · Science · doi:10.1126/science.1073619 · Cited by 287
In Vivo Seeding and Cross-Seeding of Localized Amyloidosis
Oskarsson, M. E., Paulsson, J. F., Schultz, S. W., Ingelsson, M., Westermark, P., & Westermark, G. T. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.11.016 · Cited by 281
Lee, A.-H., Heidtman, K., Hotamisligil, G. S., & Glimcher, L. H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105564108 · Cited by 277
Amyloids, prions and the inherent infectious nature of misfolded protein aggregates
Soto, C., Estrada, L., & Castilla, J. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.01.002 · Cited by 266
Self-citationDisease-Associated Prion Protein Oligomers Inhibit the 26S Proteasome
Kristiansen, M., Deriziotis, P., Dimcheff, D. E., Jackson, G. S., Ovaa, H., Naumann, H., Clarke, A. R., van Leeuwen, F. W. B., Menéndez-Benito, V., Dantuma, N. P., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.001 · Cited by 263
Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones
Maianti, J. P., McFedries, A., Foda, Z. H., Kleiner, R. E., Du, X. Q., Leissring, M. A., Tang, W.-J., Charron, M. J., Seeliger, M. A., Saghatelian, A., et al. (2014) · Nature · doi:10.1038/nature13297 · Cited by 254
Misfolded protein aggregates: Mechanisms, structures and potential for disease transmission
Moreno-Gonzalez, I., & Soto, C. (2011) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2011.04.002 · Cited by 252
Self-citationThe use of animal models in the study of diabetes mellitus.
Chatzigeorgiou, A., Halapas, A., Kalafatakis, K., & Kamper, E. F. (2009) · PubMed · Cited by 252
Amyloid as a Depot for the Formulation of Long-Acting Drugs
Maji, S. K., Schubert, D., Rivier, C., Lee, S., Rivier, J. E., & Riek, R. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060017 · Cited by 242
Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes
Miklossy, J., Qing, H., Radenovic, A., Kis, A., Vileno, B., Làszló, F., Miller, L., Martins, R. N., Waeber, G., Mooser, V., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.019 · Cited by 235
Amyloid β-Protein Inhibits Ubiquitin-dependent Protein Degradation in Vitro
Gregori, L., Fuchs, C., Figueiredo-Pereira, M. E., Van Nostrand, W. E., & Goldgaber, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19702 · Cited by 233
Evidence for Proteotoxicity in β Cells in Type 2 Diabetes
Gurlo, T., Ryazantsev, S., Huang, C.-J., Yeh, M. W., Reber, H. A., Hines, O. J., O'Brien, T. D., Glabe, C. G., & Butler, P. C. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090532 · Cited by 228
Self-citationWestwell-Roper, C. Y., Ehses, J. A., & Verchere, C. B. (2014) · Diabetes · doi:10.2337/db13-0863 · Cited by 224
Morales, R., Moreno-Gonzalez, I., & Soto, C. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003537 · Cited by 218
Self-citationAutophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity
Rivera, J. F., Costes, S., Gurlo, T., Glabe, C. G., & Butler, P. C. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71981 · Cited by 214
Self-citationTransmissible Proteins: Expanding the Prion Heresy
Soto, C. (2012) · Cell · doi:10.1016/j.cell.2012.05.007 · Cited by 212
Self-citationIslet Amyloid, Islet-Amyloid Polypeptide, and Diabetes Mellitus
Epstein, F. H., Johnson, K. H., O'Brien, T. D., Betsholtz, C., & Westermark, P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908243210806 · Cited by 205
Opie, E. L. (1901) · Journal of Experimental Medicine · doi:10.1084/jem.5.4.397 · Cited by 205
Yates, S. L., Burgess, L. H., Kocsis‐Angle, J., Antal, J. M., Dority, M. D., Embury, P. B., Piotrkowski, A. M., & Brunden, K. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741017.x · Cited by 202
Effects of beta cell granule components on human islet amyloid polypeptide fibril formation
Westermark, P., Li, Z.-C., Westermark, G. T., Leckström, A., & Steiner, D. F. (1996) · FEBS Letters · doi:10.1016/0014-5793(95)01512-4 · Cited by 197
Cefalu, W. T. (2006) · ILAR Journal · doi:10.1093/ilar.47.3.186 · Cited by 196
Westwell-Roper, C., Dai, D. L., Soukhatcheva, G., Potter, K. J., van Rooijen, N., Ehses, J. A., & Verchere, C. B. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002854 · Cited by 190
Zraika, S., Hull, R. L., Verchere, C. B., Clark, A., Potter, K. J., Fraser, P. E., Raleigh, D. P., & Kahn, S. E. (2010) · Diabetologia · doi:10.1007/s00125-010-1671-6 · Cited by 179
Betsholtz, C., Christmansson, L., Engström, U., Rorsman, F., Svensson, V., Johnson, K. H., & Westermark, P. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81467-x · Cited by 176
Quantitative Studies of Amyloid in the Islets of Langerhans
Westermark, P. (1972) · Upsala Journal of Medical Sciences · doi:10.1517/03009734000000014 · Cited by 170
Degradation of Amylin by Insulin-degrading Enzyme
Bennett, R. G., Duckworth, W. C., & Hamel, F. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006170200 · Cited by 170
Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes
Kim, J., Cheon, H., Jeong, Y. T., Quan, W., Kim, K. H., Cho, J. M., Lim, Y.-M., Oh, S. H., Jin, S., Kim, J. H., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69625 · Cited by 170
de Koning, E. J. P., Bodkin, N. L., Hansen, B. C., & Clark, A. (1993) · Diabetologia · doi:10.1007/bf00402271 · Cited by 167
Guardado-Mendoza, R., Davalli, A. M., Chavez, A. O., Hubbard, G. B., Dick, E. J., Majluf-Cruz, A., Tene-Perez, C. E., Goldschmidt, L., Hart, J., Perego, C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906471106 · Cited by 166
Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols
Camilleri, A., Zarb, C., Caruana, M., Ostermeier, U., Ghio, S., Högen, T., Schmidt, F., Giese, A., & Vassallo, N. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.06.026 · Cited by 163
Autophagy-mediated clearance of aggresomes is not a universal phenomenon
Wong, E. S. P., Tan, J. M. M., Soong, W.-E., Hussein, K., Nukina, N., Dawson, V. L., Dawson, T. M., Cuervo, A. M., & Lim, K.-L. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn157 · Cited by 159
Sakagashira, S., Hiddinga, H. J., Tateishi, K., Sanke, T., Hanabusa, T., Nanjo, K., & Eberhardt, N. L. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64848-1 · Cited by 156
Islet Amyloid Polypeptide (IAPP) Transgenic Rodents as Models for Type 2 Diabetes
Matveyenko, A. V., & Butler, P. C. (2006) · ILAR Journal · doi:10.1093/ilar.47.3.225 · Cited by 150
Self-citationRivera, J. F., Gurlo, T., Daval, M., Huang, C. J., Matveyenko, A. V., Butler, P. C., & Costes, S. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.111 · Cited by 150
Self-citationRole of Protein Misfolding and Proteostasis Deficiency in Protein Misfolding Diseases and Aging
Cuanalo-Contreras, K., Mukherjee, A., & Soto, C. A. (2013) · International Journal of Cell Biology · doi:10.1155/2013/638083 · Cited by 148
Self-citationIslet amyloid polypeptide toxicity and membrane interactions
Cao, P., Abedini, A., Wang, H., Tu, L.-H., Zhang, X., Schmidt, A. M., & Raleigh, D. P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305517110 · Cited by 146
Disease-associated amyloid and misfolded protein aggregates activate the inflammasome
Masters, S. L., & O'Neill, L. A. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.005 · Cited by 145
Feline Models of Type 2 Diabetes Mellitus
Henson, M. S., & O’Brien, T. D. (2006) · ILAR Journal · doi:10.1093/ilar.47.3.234 · Cited by 144
Longitudinal studies on the development of diabetes in individual Macaca nigra
Howard, C. F. (1986) · Diabetologia · doi:10.1007/bf00452067 · Cited by 141
β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?
Costes, S., Langen, R., Gurlo, T., Matveyenko, A. V., & Butler, P. C. (2013) · Diabetes · doi:10.2337/db12-1326 · Cited by 140
Self-citationDespa, S. I., Margulies, K. B., Chen, L., Knowlton, A. A., Havel, P. J., Taegtmeyer, H., Bers, D. M., & Despa, F. (2012) · Circulation Research · doi:10.1161/circresaha.111.258285 · Cited by 140
IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo
Venkatanarayan, A., Raulji, P., Norton, W., Chakravarti, D., Coarfa, C., Su, X., Sandur, S. K., Ramirez, M. S., Lee, J., Kingsley, C. V., et al. (2014) · Nature · doi:10.1038/nature13910 · Cited by 139
Bennett, R. G., Hamel, F. G., & Duckworth, W. C. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2315 · Cited by 127
Costes, S., Huang, C.-J., Gurlo, T., Daval, M., Matveyenko, A. V., Rizza, R. A., Butler, A. E., & Butler, P. C. (2010) · Diabetes · doi:10.2337/db10-0522 · Cited by 126
Self-citationBetsholtz, C., Svensson, V., Rorsman, F., Engström, U., Westermark, G. T., Wilander, E., Johnson, K. H., & Westermark, P. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90407-2 · Cited by 125
Li, X., Xu, G., Chen, T., Wong, Y.-S., Zhao, H., Fan, R., Gu, X., Tong, P. C. Y., & Chan, J. C. N. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.01.002 · Cited by 120
Mitochondrial dysfunction in pancreatic β-cells in Type 2 Diabetes
Mulder, H., & Ling, C. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.05.015 · Cited by 115
Role of β-Cell Prohormone Convertase (PC)1/3 in Processing of Pro-Islet Amyloid Polypeptide
Marzban, L., Trigo‐Gonzalez, G., Zhu, X., Rhodes, C. J., Halban, P. A., Steiner, D. F., & Verchere, C. B. (2004) · Diabetes · doi:10.2337/diabetes.53.1.141 · Cited by 113
Jaikaran, E. T. A. S., Nilsson, M. R., & Clark, A. (2004) · Biochemical Journal · doi:10.1042/bj20030852 · Cited by 112
Wang, J., Xu, J., Finnerty, J., Furuta, M., Steiner, D. F., & Verchere, C. B. (2001) · Diabetes · doi:10.2337/diabetes.50.3.534 · Cited by 112
Steneberg, P., Bernardo, L. M. D., Edfalk, S., Lundberg, L. A. C., Backlund, F., Östenson, C., & Edlund, H. (2013) · Diabetes · doi:10.2337/db12-1045 · Cited by 112
Calcium-activated Calpain-2 Is a Mediator of Beta Cell Dysfunction and Apoptosis in Type 2 Diabetes
Huang, C., Gurlo, T., Haataja, L., Costes, S., Daval, M., Ryazantsev, S., Wu, X., Butler, A. E., & Butler, P. C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024190 · Cited by 106
Self-citationp62/SQSTM1-Dependent Autophagy of Lewy Body-Like α-Synuclein Inclusions
Watanabe, Y., Tatebe, H., Taguchi, K., Endo, Y., Tokuda, T., Mizuno, T., Nakagawa, M., & Tanaka, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052868 · Cited by 106
Islet Amyloid Polypeptide (IAPP): A Second Amyloid in Alzheimer's Disease
Fawver, J. N., Ghiwot, Y., Koola, C., Carrera, W., Rodriguez-Rivera, J., Hernandez, C. M., Dineley, K. T., Kong, Y., Li, J., Jhamandas, J. H., et al. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666141107124538 · Cited by 101
Couce, M., Kane, L. A., O’Brien, T. D., Charlesworth, J. E., Soeller, W. C., McNeish, J. D., Kreutter, D. K., Roche, P. C., & Butler, P. C. (1996) · Diabetes · doi:10.2337/diab.45.8.1094 · Cited by 91
Self-citationAmylin deposition in the kidney of patients with diabetic nephropathy
Gong, W., Liu, Z., Zeng, C., Peng, A., Chen, H. P., Zhou, H., & Li, L. S. (2007) · Kidney International · doi:10.1038/sj.ki.5002305 · Cited by 87
Li, X., Chen, T., Wong, Y.-S., Xu, G., Fan, R., Zhao, H., & Chan, J. C. N. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.12.008 · Cited by 84
Westwell-Roper, C. Y., Chehroudi, C., Denroche, H. C., Courtade, J. A., Ehses, J. A., & Verchere, C. B. (2014) · Diabetologia · doi:10.1007/s00125-014-3447-x · Cited by 78
Microcin Amyloid Fibrils A Are Reservoir of Toxic Oligomeric Species
Shahnawaz, M., & Soto, C. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.282533 · Cited by 76
Self-citationMechanism of Amylin Fibrillization Enhancement by Heparin
Jha, S., Patil, S. M., Gibson, J. D., Nelson, C. E., Alder, N. N., & Alexandrescu, A. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.215814 · Cited by 76
B Cell Granule Peptides Affect Human Islet Amyloid Polypeptide (IAPP) Fibril Formationin Vitro
Janciauskiene, S. M., Eriksson, S., Carlemalm, E., & Åhrén, B. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7014 · Cited by 73
Amyloid peptide channels: Blockade by zinc and inhibition by Congo red (amyloid channel block)
Hirakura, Y., Yiu, W. W., Yamamoto, A., & Kagan, B. L. (2000) · Amyloid · doi:10.3109/13506120009146834 · Cited by 73
Costes, S., Gurlo, T., Rivera, J. F., & Butler, P. C. (2014) · Autophagy · doi:10.4161/auto.28478 · Cited by 70
Self-citationExogenous amyloidogenic proteins function as seeds in amyloid β-protein aggregation
Ono, K., Takahashi, R., Ikeda, T., Mizuguchi, M., Hamaguchi, T., & Yamada, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.01.002 · Cited by 70
Poirier, R., Wolfer, D. P., Welzl, H., Tracy, J., Galsworthy, M. J., Nitsch, R. M., & Mohajeri, M. H. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.003 · Cited by 69
S20G mutation of the amylin gene is associated with Type II diabetes in Japanese
Seino, S. (2001) · Diabetologia · doi:10.1007/s001250100531 · Cited by 68
Kudva, Y. C., Mueske, C. S., Butler, P. C., & Eberhardt, N. L. (1998) · Biochemical Journal · doi:10.1042/bj3310809 · Cited by 67
Self-citationBrunham, L. R., Kruit, J. K., Hayden, M. R., & Verchere, C. B. (2010) · Current Diabetes Reports · doi:10.1007/s11892-009-0090-x · Cited by 67
Role of Carboxypeptidase E in Processing of Pro-Islet Amyloid Polypeptide in β-Cells
Marzban, L., Soukhatcheva, G., & Verchere, C. B. (2004) · Endocrinology · doi:10.1210/en.2004-1175 · Cited by 67
Human islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis.
O’Brien, T. D., Butler, P. C., Kreutter, D. K., Kane, L. A., & Eberhardt, N. L. (1995) · Europe PMC (PubMed Central) · Cited by 65
Self-citationEnhancedin vitroproduction of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide
Ma, Z., Westermark, G. T., Sakagashira, S., Sanke, T., Gustavsson, Å., Sakamoto, H., Engström, U., Nanjo, K., & Westermark, P. (2001) · Amyloid · doi:10.3109/13506120108993820 · Cited by 63
Evidence for a Role of the Ubiquitin-Proteasome Pathway in Pancreatic Islets
López-Ávalos, M. D., Duvivier-Kali, V. F., Xu, G., Bonner‐Weir, S., Sharma, A., & Weir, G. C. (2006) · Diabetes · doi:10.2337/db05-0450 · Cited by 63
Thiol reducing compounds prevent human amylin‐evoked cytotoxicity
Konarkowska, B., Aitken, J. F., Kistler, J., Zhang, S., & Cooper, G. J. S. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04903.x · Cited by 61
Lee, S. C., Hashim, Y., Li, J. K. Y., Ko, G. T. C., Critchley, J., Cockram, C. S., & Chan, J. C. N. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01244.x · Cited by 59
Zhang, S., Liu, H., Chuang, C.-L., Li, X., Au, M., Zhang, L., Phillips, A. R. J., Scott, D. W., & Cooper, G. J. S. (2014) · The FASEB Journal · doi:10.1096/fj.14-251744 · Cited by 49
Amyloid Inhibitors and β-Sheet Breakers
Soto, C. A., & Estrada, L. D. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_18 · Cited by 48
Self-citationMulder, H., Åhrén, B., & Sundler, F. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.6.e1008 · Cited by 48
Zraika, S., Hull, R. L., Udayasankar, J., Clark, A., Utzschneider, K. M., Tong, J., Gerchman, F., & Kahn, S. E. (2007) · Diabetes · doi:10.2337/db06-0430 · Cited by 43
Macrophages and pancreatic islet amyloidosis
de Koning, E. J. P., van den Brand, J., Mott, V. L., CHARGÉ, S. B. P., Hansen, B. C., Bodkin, N. L., Morris, J. F., & Clark, A. (1998) · Amyloid · doi:10.3109/13506129809007297 · Cited by 42
Zraika, S., Aston‐Mourney, K., Marek, P., Hull, R. L., Green, P. S., Udayasankar, J., Subramanian, S. L., Raleigh, D. P., & Kahn, S. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.082032 · Cited by 41
Kirilyuk, A., Shimoji, M., Catania, J., Sahu, G., Pattabiraman, N., Giordano, A., Albanese, C., Mocchetti, I., Toretsky, J. A., Uversky, V. N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048243 · Cited by 39
Chu, K. Y., Li, H., Wada, K., & Johnson, J. D. (2011) · Diabetologia · doi:10.1007/s00125-011-2323-1 · Cited by 37
Autophagy protects against human islet amyloid polypeptide‐associated apoptosis
Morita, S., Sakagashira, S., Shimajiri, Y., Eberhardt, N. L., Kondo, T., Kondo, T., & Sanke, T. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00065.x · Cited by 36
Degradation of islet amyloid polypeptide by neprilysin
Guan, H., Chow, K. M., Shah, R. N., Rhodes, C. J., & Hersh, L. B. (2012) · Diabetologia · doi:10.1007/s00125-012-2678-y · Cited by 36
Identification of the metal associated with the insulin degrading enzyme
Ebrahim, A., Hamel, F. G., Bennett, R. G., & Duckworth, W. C. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)92094-z · Cited by 32
Ma, Z., Westermark, G. T., Johnson, K. H., Brien, T. D. O., & Westermark, P. (1998) · Amyloid · doi:10.3109/13506129809007298 · Cited by 31
Glucose Stimulates and Potentiates Islet Amyloid Polypeptide Secretion by the B-Cell
Kahn, S., Fujimoto, W., D'Alessio, D., Ensinck, J., & Porte, D. (1991) · Hormone and Metabolic Research · doi:10.1055/s-2007-1003759 · Cited by 28
Maetzler, W., Stoycheva, V., Schmid, B., Schulte, C., Hauser, A., Brockmann, K., Melms, A., Gasser, T., & Berg, D. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101197 · Cited by 25
Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets?
Westermark, P., Andersson, A., & Westermark, G. T. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0007-2 · Cited by 24
Human Amylin Stimulates Inflammatory Cytokine Secretion from Human Glioma Cells
Gitter, B. D., Cox, L. M., Carlson, C. D., & May, P. C. (2000) · NeuroImmunoModulation · doi:10.1159/000026432 · Cited by 19
Feng, N., Xiaowei, M., Xiao-wei, W., Junqing, Z., Aimei, D., Jin, M., Hong, Z., & Xiaohui, G. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20140521 · Cited by 15
[On occurrence of island amyloidosis of the pancreas in diabetes mellitus].
Ludwig, G., & Heitner, H. D. (1967) · PubMed · Cited by 9
Cited by
The proteostasis network and its decline in ageing
Hipp, M. S., Kasturi, P., & Hartl, F. U. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0101-y · Cited by 1,642
Mechanisms controlling pancreatic islet cell function in insulin secretion
Campbell, J. E., & Newgard, C. B. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00317-7 · Cited by 629
Type 2 diabetes and quality of life
Trikkalinou, A., Papazafiropoulou, A. K., & Melidonis, A. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i4.120 · Cited by 597
Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms
Xu, L., Li, Y., Dai, Y., & Peng, J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.015 · Cited by 452
Oxidative stress and calcium dysregulation by palmitate in type 2 diabetes
Ly, L. D., Xu, S., Choi, S.-K., Ha, C.-M., Thoudam, T., Cha, S.-K., Wiederkehr, A., Wollheim, C. B., Lee, I.-K., & Park, K.-S. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.157 · Cited by 378
Metadata
- Authors
- Mukherjee, A., Morales-Scheihing, D., Butler, P. C., & Soto, C.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 21
- Issue
- 7
- Pages
- 439-449
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W1595575404
- Cited by
- 342
- References
- 160
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.